Loading...
01/10 19:55
Loading...
Access earnings results, analyst expectations, report, slides, earnings call, and transcript.
The earnings call summary highlights strong financial metrics, optimistic guidance, and strategic acquisitions like AccessOne, which align with market expansion and product development goals. The Q&A session revealed analyst confidence in AI integration and new product offerings, despite some uncertainty regarding specific revenue details. The company's market cap suggests a moderate reaction, leading to a positive stock price movement prediction of 2% to 8% over the next two weeks.
Total Revenue $117.3 million, an increase of 15% year-over-year. The increase was attributed to strong performance on the top line.
Average Health Care Services Clients (AHSCs) 4,467, an increase of 56 AHSCs from the prior quarter and 298 in the prior year. This growth was in line with expectations.
Revenue per Average Health Care Services Client $26,249, up 7% year-over-year and flat quarter-over-quarter. This was also in line with expectations.
Net Income $700,000, marking the first-ever positive net income quarter for the company. This milestone reflects the strength of the business and financial model.
Adjusted EBITDA $22 million, an increase of $16 million year-over-year, with an adjusted EBITDA margin of 19%. This improvement highlights strong profitability growth.
Cash and Cash Equivalents $98.3 million, compared to $90.9 million in the prior quarter. This increase reflects improved cash management.
Operating Cash Flow $14.8 million, up $3.8 million year-over-year. This growth demonstrates continued operational efficiency.
Free Cash Flow $9.6 million, up $6 million year-over-year. This marks the fourth consecutive quarter of positive free cash flow.
Acquisition of AccessOne: Phreesia announced a definitive agreement to acquire AccessOne for $160 million. This acquisition is expected to expand Phreesia's addressable market by $6 billion and contribute approximately $35 million in annualized revenue and $11 million in annualized adjusted EBITDA. The acquisition complements Phreesia's payment strategy and strengthens its ability to help providers improve collections while preserving patient trust.
Expansion of Total Addressable Market (TAM): The AccessOne acquisition is expected to expand Phreesia's TAM by $6 billion in the payment solutions space. Additionally, the network solutions TAM increased by $6 billion due to a larger pool of life sciences marketing dollars. Combined, the TAM is expected to grow from $10 billion to $24 billion.
Revenue Growth: Total revenue for Q2 FY2026 was $117.3 million, a 15% year-over-year increase. Average revenue per healthcare services client was $26,249, up 7% year-over-year.
Profitability Milestone: Phreesia achieved positive net income for the first time in its history, with $700,000 in net income for Q2 FY2026. Adjusted EBITDA was $22 million, a $16 million year-over-year increase, with a 19% adjusted EBITDA margin.
Cash Flow Improvements: Operating cash flow was $14.8 million, up $3.8 million year-over-year. Free cash flow was $9.6 million, up $6 million year-over-year. Positive operating and free cash flow have been achieved for four consecutive quarters.
Leadership Appointments: Evan Roberts and David Linetsky were named President of Provider Solutions and Network Solutions, respectively, reflecting their leadership roles and contributions to Phreesia's mission.
Acquisition Financing Risks: The acquisition of AccessOne for $160 million will be financed through a combination of cash from the balance sheet and a new fully committed bridge loan facility. This introduces financial risks, including potential strain on cash reserves and increased debt obligations.
Regulatory Approval Risks: The AccessOne transaction is subject to customary closing conditions and regulatory approvals, which could delay or prevent the acquisition from being finalized.
Integration Challenges: Post-acquisition, integrating AccessOne into Phreesia's operations may present challenges, including aligning systems, processes, and cultures, which could impact operational efficiency and financial performance.
Revenue Dependency Risks: The company’s updated total addressable market (TAM) expansion relies heavily on the success of the AccessOne acquisition and the ability to draw from a larger pool of life sciences marketing dollars. Failure to achieve these goals could limit revenue growth.
Cash Flow Variability: The company acknowledges variability in cash flow improvements on a quarter-to-quarter basis due to timing of invoicing, payments, and CapEx, which could impact financial stability.
Revenue Outlook: Phreesia is maintaining its revenue outlook for fiscal year 2026 at a range of $472 million to $482 million.
Adjusted EBITDA Outlook: The adjusted EBITDA outlook for fiscal year 2026 has been updated to a range of $87 million to $92 million, an increase of $2 million at both the top and bottom ends of the previous range.
Acquisition Impact: The acquisition of AccessOne is expected to close during the third or early fourth quarter of fiscal year 2026. AccessOne is projected to contribute approximately $35 million in annualized revenue and $11 million in annualized adjusted EBITDA. The fiscal 2026 outlook will be updated post-acquisition to reflect its contribution.
Total Addressable Market (TAM) Expansion: The AccessOne acquisition is expected to expand Phreesia's addressable market by $6 billion. Additionally, the network solutions TAM is expected to increase by $6 billion, bringing the total TAM to approximately $24 billion from $10 billion.
Average Healthcare Services Clients (AHSCs): Phreesia reiterates its outlook to reach approximately 4,500 AHSCs in fiscal year 2026, with total revenue per AHSC expected to increase compared to fiscal year 2025.
The selected topic was not discussed during the call.
The earnings call presents strong financial metrics, including consecutive positive net income and increased cash flow, which are positive indicators. The Q&A session highlights a cautious but optimistic outlook, with plans for strategic investments and growth. While some management responses lack clarity, the overall sentiment is positive due to strong cash flow, margin expansion, and growth potential from acquisitions. The market cap suggests a moderate reaction, leading to a positive stock price movement prediction.
The earnings call summary highlights strong financial metrics, optimistic guidance, and strategic acquisitions like AccessOne, which align with market expansion and product development goals. The Q&A session revealed analyst confidence in AI integration and new product offerings, despite some uncertainty regarding specific revenue details. The company's market cap suggests a moderate reaction, leading to a positive stock price movement prediction of 2% to 8% over the next two weeks.
The earnings call indicates strong financial performance with a 15% revenue increase and improved cash flow. Positive free cash flow and a strong cash position, along with a focus on product development, contribute to a positive outlook. Despite concerns about economic factors, management's resilience and strategic focus on growth and shareholder value are reassuring. The Q&A reveals no significant risks or uncertainties, and management's opportunistic share repurchase plan suggests confidence in future performance. Given the company's small-cap status, a positive stock price movement is expected.
The earnings call revealed strong financial performance, including a 15% revenue increase and solid EBITDA growth. The share repurchase plan indicates confidence in stock value, likely boosting investor sentiment. While regulatory risks exist, management's focus on product value and resilience in client engagement are reassuring. The positive financial metrics and strategic initiatives outweigh the hesitancy in client decision-making, suggesting a positive stock price movement. Given the market cap of $1.2 billion, the reaction is expected to be in the positive range of 2% to 8% over the next two weeks.
All transcripts are sourced directly from the official live webcast or the company’s official investor relations website. We use the exact words spoken during the call with no paraphrasing of the core discussion.
Full verbatim transcripts are typically published within 4–12 hours after the call ends. Same-day availability is guaranteed for all S&P 500 and most mid-cap companies.
No material content is ever changed or summarized in the “Full Transcript” section. We only correct obvious spoken typos (e.g., “um”, “ah”, repeated 10 times”, or clear misspoken ticker symbols) and add speaker names/titles for readability. Every substantive sentence remains 100% as spoken.
When audio quality is poor or multiple speakers talk over each other, we mark the section instead of guessing. This ensures complete accuracy rather than introducing potential errors.
They are generated by a specialized financial-language model trained exclusively on 15+ years of earnings transcripts. The model extracts financial figures, guidance, and tone with 97%+ accuracy and is regularly validated against human analysts. The full raw transcript always remains available for verification.
